From: Clinical and bacteriological profile of diabetic foot infections in a tertiary care
Antimicrobial agents | Gram-positive organisms (% resistant) | |||||
---|---|---|---|---|---|---|
S. aureus | Enterococcus spp. | Group B Streptococcus | ||||
n = 116 | (%) | n = 63 | (%) | n = 47 | (%) | |
Ampicillin | 59 | 50.8 | – | – | 0 | 0.0 |
Clindamycin | 56 | 48.2 | – | – | 5 | 10.6 |
Cloxacillin | 60 | 51.7 | – | – | – | – |
Co-amoxiclav | 59 | 50.8 | – | – | 0 | 0.0 |
Erythromycin | 65 | 56.0 | 40 | 63.5 | 8 | 17.0 |
Fusidic acid | 60 | 51.7 | – | – | – | – |
Gentamicin | 52 | 44.8 | 1 | 1.6 | 2 | 4.3 |
Penicillin | 110 | 94.8 | 10 | 15.9 | 0 | 0.0 |
Rifampicin | 1 | 0.8 | – | – | – | – |
Sulfamethoxazole-Trimethoprim | 30 | 25.8 | – | – | – | – |
Tetracycline | 72 | 62.0 | 0 | 0.0 | 24 | 51.0 |
Vancomycin | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |